
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.(002223.SZ)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 6,726 | 6,894 | 7,102 | 7,972 | 7,566 | 7,904 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 1,759 | 1,482 | 1,595 | 2,396 | 1,806 | 1,482 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., formerly known as Yuwell Medical, was established in 1998 and is headquartered in Shanghai, China. The company operates globally, manufacturing and distributing a diverse array of medical devices in both domestic and international markets. Its extensive product catalog includes sophisticated respiratory therapy solutions, such as ventilators, humidifiers, oxygen generators, nebulizers, and advanced non-invasive ventilator data management systems. Yuwell also offers comprehensive chronic disease monitoring systems, featuring sphygmomanometers, blood glucose meters, pulse oximeters, thermometers, stethoscopes, alongside general practice diagnostic tools and in-hospital blood glucose management platforms. Furthermore, the company provides cutting-edge imaging diagnosis and treatment solutions, including ultrasound diagnostic imaging, interventional, and minimally invasive technologies. Its offerings extend to infection control and disinfection products, as well as specialized ophthalmology and vision care items like microscopes, eye surgical instruments, ophthalmoscopes, synoptophores, and keratometers. Defibrillator monitors are also part of their product range. Additionally, Yuwell supplies a broad spectrum of durable medical equipment and consumables, encompassing basic and microsurgical tools, instruments for ENT and orthopedics, endoscopic devices, dental appliances, acupuncture and electronic acupuncture products, absorbable sutures, and venous indwelling needles.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., formerly known as Yuwell Medical, was established in 1998 and is headquartered in Shanghai, China. The company operates globally, manufacturing and distributing a diverse array of medical devices in both domestic and international markets. Its extensive product catalog includes sophisticated respiratory therapy solutions, such as ventilators, humidifiers, oxygen generators, nebulizers, and advanced non-invasive ventilator data management systems. Yuwell also offers comprehensive chronic disease monitoring systems, featuring sphygmomanometers, blood glucose meters, pulse oximeters, thermometers, stethoscopes, alongside general practice diagnostic tools and in-hospital blood glucose management platforms. Furthermore, the company provides cutting-edge imaging diagnosis and treatment solutions, including ultrasound diagnostic imaging, interventional, and minimally invasive technologies. Its offerings extend to infection control and disinfection products, as well as specialized ophthalmology and vision care items like microscopes, eye surgical instruments, ophthalmoscopes, synoptophores, and keratometers. Defibrillator monitors are also part of their product range. Additionally, Yuwell supplies a broad spectrum of durable medical equipment and consumables, encompassing basic and microsurgical tools, instruments for ENT and orthopedics, endoscopic devices, dental appliances, acupuncture and electronic acupuncture products, absorbable sutures, and venous indwelling needles.
